COMPAGNIE CHARGEURS INVEST (CRI.PA) Fundamental Analysis & Valuation

EPA:CRI • FR0000130692

Current stock price

8.86 EUR
+0.19 (+2.19%)
Last:

This CRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CRI.PA Profitability Analysis

1.1 Basic Checks

  • CRI had positive earnings in the past year.
  • CRI had a positive operating cash flow in the past year.
  • Of the past 5 years CRI 4 years were profitable.
  • In multiple years CRI reported negative operating cash flow during the last 5 years.
CRI.PA Yearly Net Income VS EBIT VS OCF VS FCFCRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • CRI has a Return On Assets of 0.28%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
  • The Return On Equity of CRI (1.03%) is worse than 68.75% of its industry peers.
  • CRI's Return On Invested Capital of 5.14% is fine compared to the rest of the industry. CRI outperforms 62.50% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRI is in line with the industry average of 6.43%.
  • The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.28%
ROE 1.03%
ROIC 5.14%
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
CRI.PA Yearly ROA, ROE, ROICCRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.37%, CRI is doing worse than 68.75% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CRI has declined.
  • CRI has a Operating Margin (6.41%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
  • The Gross Margin of CRI (28.51%) is worse than 75.00% of its industry peers.
  • CRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.41%
PM (TTM) 0.37%
GM 28.51%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
CRI.PA Yearly Profit, Operating, Gross MarginsCRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CRI.PA Health Analysis

2.1 Basic Checks

  • CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CRI has more shares outstanding
  • The number of shares outstanding for CRI has been increased compared to 5 years ago.
  • Compared to 1 year ago, CRI has an improved debt to assets ratio.
CRI.PA Yearly Shares OutstandingCRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CRI.PA Yearly Total Debt VS Total AssetsCRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.20, we must say that CRI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.20, CRI is doing worse than 68.75% of the companies in the same industry.
  • CRI has a debt to FCF ratio of 124.09. This is a negative value and a sign of low solvency as CRI would need 124.09 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 124.09, CRI perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
  • CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
  • CRI's Debt to Equity ratio of 1.38 is on the low side compared to the rest of the industry. CRI is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 124.09
Altman-Z 1.2
ROIC/WACC0.83
WACC6.23%
CRI.PA Yearly LT Debt VS Equity VS FCFCRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.30, CRI is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
  • CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CRI (0.86) is worse than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.86
CRI.PA Yearly Current Assets VS Current LiabilitesCRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CRI.PA Growth Analysis

3.1 Past

  • CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.24%, which is quite impressive.
  • CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
  • Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
  • The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%

3.2 Future

  • Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 33.91% on average per year.
  • CRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.28% yearly.
EPS Next Y-30.25%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year-1.02%
Revenue Next 2Y2.35%
Revenue Next 3Y3.28%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRI.PA Yearly Revenue VS EstimatesCRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
CRI.PA Yearly EPS VS EstimatesCRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. CRI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 68.15, the valuation of CRI can be described as expensive.
  • 68.75% of the companies in the same industry are cheaper than CRI, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.50. CRI is valued rather expensively when compared to this.
  • CRI is valuated reasonably with a Price/Forward Earnings ratio of 11.03.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRI indicates a rather cheap valuation: CRI is cheaper than 81.25% of the companies listed in the same industry.
  • CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 68.15
Fwd PE 11.03
CRI.PA Price Earnings VS Forward Price EarningsCRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 75.00% of the companies in the same industry are more expensive than CRI, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 64.86
EV/EBITDA 6.84
CRI.PA Per share dataCRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CRI's earnings are expected to grow with 33.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.84%
EPS Next 3Y33.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. CRI.PA Dividend Analysis

5.1 Amount

  • CRI has a Yearly Dividend Yield of 1.46%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 3.14, CRI is paying slightly less dividend.
  • CRI's Dividend Yield is slightly below the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.46%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRI.PA Yearly Dividends per shareCRI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
CRI.PA Yearly Income VS Free CF VS DividendCRI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M
CRI.PA Dividend Payout.CRI.PA Dividend Payout, showing the Payout Ratio.CRI.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CRI.PA Fundamentals: All Metrics, Ratios and Statistics

COMPAGNIE CHARGEURS INVEST

EPA:CRI (3/24/2026, 4:21:39 PM)

8.86

+0.19 (+2.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)03-19
Earnings (Next)N/A
Inst Owners4.62%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap220.53M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target12.41 (40.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.46%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.39%
PT rev (3m)7.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)15.09%
EPS NY rev (3m)-35.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.33%
Revenue NY rev (3m)-3.33%
Valuation
Industry RankSector Rank
PE 68.15
Fwd PE 11.03
P/S 0.3
P/FCF 64.86
P/OCF 9.27
P/B 0.84
P/tB N/A
EV/EBITDA 6.84
EPS(TTM)0.13
EY1.47%
EPS(NY)0.8
Fwd EY9.06%
FCF(TTM)0.14
FCFY1.54%
OCF(TTM)0.96
OCFY10.79%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
Industry RankSector Rank
ROA 0.28%
ROE 1.03%
ROCE 7.02%
ROIC 5.14%
ROICexc 6.13%
ROICexgc 13.12%
OM 6.41%
PM (TTM) 0.37%
GM 28.51%
FCFM 0.47%
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 124.09
Debt/EBITDA 4.67
Cap/Depr 66.89%
Cap/Sales 2.8%
Interest Coverage 250
Cash Conversion 30.87%
Profit Quality 125.93%
Current Ratio 1.3
Quick Ratio 0.86
Altman-Z 1.2
F-Score7
WACC6.23%
ROIC/WACC0.83
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-30.25%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year-1.02%
Revenue Next 2Y2.35%
Revenue Next 3Y3.28%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year102.09%
EBIT Next 3Y37.85%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%

COMPAGNIE CHARGEURS INVEST / CRI.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.


What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Fairly Valued.


What is the profitability of CRI stock?

COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CRI stock?

The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 68.15 and the Price/Book (PB) ratio is 0.84.


How financially healthy is COMPAGNIE CHARGEURS INVEST?

The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.